CAGR: 8.5%Current Market Size: USD 99.6 BillionFastest Growing Region: APAC
Largest Market: North AmericaProjection Time: 2023-2030Base Year: 2022
The global anti-counterfeit pharmaceutical packaging market is expected to grow from USD 99.6 billion in 2022 to USD 191.2 billion by 2030, at a CAGR of 8.5% during the Projection period 2023-2030. The increased production of pharmaceutical products mainly drives the growth of the anti-counterfeit pharmaceutical packaging market.
Anti-counterfeit pharmaceutical packaging is a method of preventing fake labelling and identification of pharmaceutical medicines. Pharmaceutical packaging that is resistant to counterfeiting aids in protecting the integrity of the original product throughout the supply chain. Anti-counterfeit packaging ensures that the original manufacturer's package code has not been altered due to the increasing global acceptance of such packaging, particularly by pharmaceutical industries. Furthermore, increased consumer awareness of the negative effects of counterfeit goods is anticipated to fuel growth. Due to growing worries about the dilution of brand identification by top manufacturers worldwide, the industry is predicted to experience rapid expansion. According to The Hindu, HP India's Anti-Counterfeiting and Fraud (ACF) Program confiscated 4,98,000 counterfeit products worth INR 40 crore between July 2020 and September 2021, which indicates a serious threat to consumer health in India and throughout the world. The regions most impacted by this trade are those with emerging economies, which are also known to import most medications. Procedures to improve supply chain security for the pharmaceutical business have been developed in nations like China, India, South Korea, Brazil, and Turkey. The US Food and Drug Administration has approved silicon dioxide-based tags as generally recognised as safe (GRAS) and deemed them suitable for use on food products.
Sample Request: - Global Anti-Counterfeit Pharmaceutical Packaging Market
Market Dynamics:
Drivers:
Due to the rising number of counterfeit products, which can impair both the reputation of pharmaceutical firms and the health of patients, there is an increased need for secure pharmaceutical medication packaging, which is the primary cause of the expansion of anti-counterfeit pharmaceutical packaging. The World Health Organization estimates that one in ten medical items sold in underdeveloped nations is fake or of poor quality. The financial burden - up to $200 billion annually - is significant, as are the costs to individual and societal health. The market expansion of anti-counterfeit pharmaceutical packaging is anticipated to be aided by the increasing implementation of policies and regulations for anti-counterfeiting packaging to prevent the tampering or counterfeiting of packaged original and branded medications.
Restraints:
Due to the high cost of anti-counterfeiting technology adoption, small producers sometimes disregard drug safety. The pharmaceutical packaging industry's expansion is anticipated to be hampered by this. The rise in cases when patients buy medicines without consulting a doctor is actively pushing fake drugs. In a cohort of 400 adults, 5% of adults reported using antibiotics without a prescription in the previous 12 months, according to the American Society for Microbiology. This will probably hurt the market expansion.
Opportunities:
It is anticipated that rising consumer demand for expensive life-saving medications would fuel the growth of the black market, creating a window of opportunity for anti-counterfeiting methods for such medications. As a result, the market for anti-counterfeit pharmaceutical packaging is anticipated to increase due to the rising need for life-saving medications. According to estimates, 342 persons in North America pass away each day due to inadequate adherence to life-saving medication. Due to the region's thriving pharmaceutical industry and lax government regulations that permit drug stores to sell prescription medications without registering, the Asia Pacific region is anticipated to offer significant growth possibilities for the anti-counterfeit pharmaceutical packaging market. According to the Pharmaceutical Security Institute, most fake pharmaceuticals are produced worldwide in Asia.
Challenges:
Anti-counterfeit packaging must be produced at high setup and innovation costs, which deters potential customers and new competitors from utilizing such services and slows market expansion. Additionally, some current technologies, like barcodes and QR codes, are simple to copy without sufficient consumer understanding, restricting industry expansion.
Segmentation Analysis:
The global anti-counterfeit pharmaceutical packaging market has been segmented based on product, application, and region.
By Product
The product segment is overt, track & trace, forensic, and covert. The covert segment led the largest share of the anti-counterfeit pharmaceutical packaging market with a market share of around 49% in 2022. Because the garment and apparel business strongly demands inexpensive, secure packaging for use in the food industry. Additionally, the market is anticipated to increase over the course of the Projection period due to the rising adoption of covert techniques by the economies in the Asia Pacific. Because of the high level of product security and the difficulty in forging genuine products, the market for security labels is anticipated to become one of the most lucrative covert security approaches. Additionally, the market expansion over the next nine years is projected to be driven by the increased demand for such products for FMCG goods.
By Application
The application segment is medical & supplies, pharmaceutical & healthcare, gloves, syringes & needles, surgical tapes, scissors, and others. The pharmaceutical & healthcare segment led the largest share of the anti-counterfeit pharmaceutical packaging market with a market share of around 37% in 2022. One of the most valuable segments of global commerce in illegally copied items is counterfeit pharmaceuticals. Millions of individuals worldwide suffer damage and even death from fake medications. It causes significant harm to the brands of major pharmaceutical makers. Several reports of fraudulent COVID vaccines have recently been given to various nations' populations. For instance, the discovery of fake Covishield (produced by the Serum Institute of India) by the World Health Organization (WHO) raised serious concerns among all relevant parties. Additionally, Pfizer's fake vaccination vials were found in various locations inside and outside the United States.
Global Anti-Counterfeit Pharmaceutical Packaging Market - Sales Analysis.
The sale of the anti-counterfeit pharmaceutical packaging market expanded at a CAGR of 5% from 2016 to 2022.
The usage of adaptable ultraviolet and infrared ray print and the creation of the label navigation application are two recent developments in the market. Gerresheimer AG increased production in Wertheim starting in January 2022. According to an analysis by FMI, the market for anti-counterfeit pharmaceutical packaging is anticipated to grow by 20 basis share points (BPS) in H1-2022 (O) compared to H1-2021. A spike in BPS change of 30 BPS has been seen when comparing the H1-2022 projected and H1-2022 outlook periods.
One of the main issues raised advocates packaging design to oppose the unlawful use of packaged generic and branded pharmaceuticals, highlighting the role of packaging and how it works in conjunction with anti-counterfeit technology. The market for anti-counterfeit pharmaceutical packaging is expected to expand due to several organizations, like the US FDA and WHO, enforcing the necessary laws to stop the distribution of illegitimate drugs in the marketplace. These initiatives encourage pharmaceutical companies to consider novel ideas. A favourable growth rate is observed in the anti-counterfeit pharmaceutical packaging market, and this trend is anticipated to last throughout the projected period.
Thus, owing to the aforementioned factors, the global anti-counterfeit pharmaceutical packaging market is expected to grow at a CAGR of 8.5% during the Projection period from 2023 to 2030.
By Regional Analysis:
The regions analyzed for the anti-counterfeit pharmaceutical packaging market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North America region dominated the anti-counterfeit pharmaceutical packaging market and held a 38% share of the market revenue in 2022.
Global Anti-Counterfeit Pharmaceutical Packaging Market - Country Analysis:
Germany's anti-counterfeit pharmaceutical packaging market size was valued at USD 7.47 billion in 2022 and is expected to reach USD 14.45 billion by 2030, at a CAGR of 8.6% from 2023 to 2030. Over the course of the Projection period, the industry is anticipated to grow rapidly because of the demand for product authentication methods in the fast-moving consumer goods (FMCG) sector.
China’s anti-counterfeit pharmaceutical packaging market size was valued at USD 7.74 billion in 2022 and is expected to reach USD 15.3 billion by 2030, at a CAGR of 8.9% from 2023 to 2030. Due to the economy's numerous makers of medicinal products. In addition, the market is anticipated to rise rapidly as Chinese manufacturers increasingly implement such product security technology.
India's anti-counterfeit pharmaceutical packaging market size was valued at USD 5.96 billion in 2022 and is expected to reach USD 11.7 billion by 2030, at a CAGR of 8.8% from 2023 to 2030.
According to the Pharmaceutical Security Institute, Asia is where the majority of fake pharmaceuticals are produced worldwide. Additionally, India is the world's largest producer of pharmaceuticals. Therefore the presence of fake drugs could be problematic for this populous region.
Key Industry Players Analysis:
To increase their market position in the global anti-counterfeit pharmaceutical packaging business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.
Latest Development:
Report Metrics
Report Attribute |
Details |
Study Period |
2022-2030 |
Base year |
2022 |
CAGR (%) |
8.5% |
Market Size |
99.6 billion in 2022 |
Projection period |
2023-2030 |
Projection unit |
Value (USD) |
Segments covered |
By Product, By Application, and By Region |
Report Scope |
Revenue Projection, competitive landscape, company ranking, growth factors, and trends |
Companies covered |
Alien Technology, ATL Security Label Systems, Stevanato Group, CCL Industries, SICPA Holdings, Savi Technology Inc., Alpvision SA, OpSec Security Inc., Zebra Technologies Corporation, Ardagh Group S.A., Nipro Corporation, Authentix Inc., and TruTag Technologies, Inc. |
By Product |
|
By Application |
|
Regional scope |
|
Scope of the Report
Global Anti-Counterfeit Pharmaceutical Packaging Market By Product :
Global Anti-Counterfeit Pharmaceutical Packaging Market By Application:
Global Anti-Counterfeit Pharmaceutical Packaging Market By Region:
Global anti-counterfeit pharmaceutical packaging market is expected to reach USD 191.2 billion by 2030.
Leading market players active in the global anti-counterfeit pharmaceutical packaging market are Avery Dennison Corporation, 3M Track and Trace Solutions, Alien Technology, CFC International, Inc., Authentix, Inc., Impinj, Inc., Digimarc Corporation, ATL Security Label Systems, Sicpa Holding, and Applied DNA Sciences among other
The anti-counterfeit pharmaceutical packaging market is projected to have a CAGR of 8.5%.
Due to the rising number of counterfeit products, which can impair both the reputation of pharmaceutical firms and the health of patients, there is an increased need for secure pharmaceutical medication packaging, which is the primary cause of the expansion of anti-counterfeit pharmaceutical packaging.
Based on the application, the global anti-counterfeit pharmaceutical packaging market has been segmented into medical & supplies, pharmaceutical & healthcare, gloves, syringes & needles, surgical tapes, scissors, and others.
Political Factors- Before deciding whether to grow, the anti-counterfeit pharmaceutical packaging market should carefully examine the tax laws that apply to the industry. Industries that the government views as high priority will gain more from tax policy. In an effort to attract foreign direct investment, the governments of many developing countries are actively seeking to reduce company taxes. These countries should be considered in the anti-counterfeit pharmaceutical packaging market because they have low tax rates that will make it easier to make money and invest in R&D, innovation, and new product development initiatives.
Economical Factors- Rising inflation may negatively affect the anti-counterfeit pharmaceutical packaging market's ability to increase its income since it decreases the purchasing power of money and discourages consumers from making purchases of products and services. The profitability of a corporation may be impacted by exchange rate changes. The anti-counterfeit pharmaceutical packaging market should conduct this study in order to effectively Projection exchange rate changes and minimise unwanted trade and company performance repercussions. The cost of the loans taken out will go up overall if the interest rate is high since the anti-counterfeit pharmaceutical packaging market will have to make payments at a high rate of interest.
Social Factor- Economic problems and consumption trends are closely intertwined. When customers have more disposable income and are eager to spend more on goods and services to improve their lifestyles, the anti-counterfeit pharmaceutical packaging market enjoys exciting growth potential. This is due to the ease with which new goods and services can be introduced to these clients, as well as the higher likelihood of revenue growth. In order to adjust its marketing mix strategies, the anti-counterfeit pharmaceutical packaging market must carefully examine consumption/spending trends and the increasingly discerning tastes of modern consumers. The anti-counterfeit pharmaceutical packaging market must also understand whether consumer behaviour is motivated by hedonic or utilitarian factors. An important consumer behaviour factor that can affect the performance of the anti-counterfeit pharmaceutical packaging market is the level of ethnocentrism.
Technological Factors- Since these countries make it easier for firms to pursue objectives like cost reduction, innovation, and value creation, the anti-counterfeit pharmaceutical packaging market should favour those countries with superior technical infrastructure. It also demonstrates that it will be more challenging for the anti-counterfeit pharmaceutical packaging market to employ technology to sustainably achieve a competitive edge because it might be easily replicated by competitors. By making the right technical investments, anti-counterfeit pharmaceutical packaging market can enhance the client experience, create operational efficiencies, and position itself as an innovative company.
Environmental Factors- A significant trend in many industries is the development of renewable technology to reduce reliance on natural resources. The anti-counterfeit pharmaceutical packaging market should evaluate how well a country's technological infrastructure supports the use of renewable technologies in order to capitalise on this environmental trend. Governments in certain regions of the world offer alluring incentives to adopt renewable energy. By taking advantage of the chance and investing in renewable energy sources, the anti-counterfeit pharmaceutical packaging market may be able to realise its objectives for sustainable corporate development.
Legal Factors- Employment law refers to a large area of laws that defend workers' rights, including those to a fair wage, equality, equity, inclusion, fairness, and their bodily and emotional safety. In some countries, employment laws are not effectively enforced, while in others, breaching any of the outlined employee rights is punishable by heavy fines. While entering or conducting business in these countries, the anti-counterfeit pharmaceutical packaging market should ensure the security of the working environment. Both direct and indirect discrimination must be prevented, thus the right processes must be in place. Effective adherence to employment laws can help the anti-counterfeit pharmaceutical packaging market improve its employer brand reputation, which is essential for drawing and retaining top talent in the market.
List of Table
List of Figures